Get the Stockscreener App
32.33
8.89%
2.62
Zai Lab Limited Adr stock is traded at $32.33, with a volume of 872.68K.
It is up +8.89% in the last 24 hours and down -7.81% over the past month.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
See More
Previous Close:
$29.71
Open:
$31.83
24h Volume:
872.68K
Relative Volume:
0.81
Market Cap:
$3.46B
Revenue:
$355.75M
Net Income/Loss:
$-270.85M
P/E Ratio:
-11.97
EPS:
-2.7
Net Cash Flow:
$-218.63M
1W Performance:
+6.48%
1M Performance:
-7.81%
6M Performance:
+12.25%
1Y Performance:
+115.81%
1-Day Range:
$31.13
$32.70
1-Week Range:
$28.34
$32.70
52-Week Range:
$15.00
$39.77
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Name
Zai Lab Limited Adr
Sector
Industry
Phone
862161632588
Address
4560 JINKE ROAD, SHANGHAI
Compare ZLAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
32.40 | 3.46B | 355.75M | -270.85M | -218.63M | -2.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.69 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.23 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
600.69 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.00 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.05 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-14-23 | Initiated | Morgan Stanley | Overweight |
| Aug-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-22 | Initiated | Macquarie | Outperform |
| Oct-12-21 | Initiated | Bernstein | Mkt Perform |
| Apr-28-20 | Initiated | Goldman | Buy |
| Apr-15-20 | Initiated | Guggenheim | Buy |
| Jul-12-19 | Initiated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
| Jan-29-19 | Initiated | Credit Suisse | Outperform |
| Nov-21-18 | Initiated | Jefferies | Buy |
| Jun-21-18 | Resumed | Leerink Partners | Outperform |
| Feb-14-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-16-17 | Initiated | JP Morgan | Neutral |
| Oct-16-17 | Initiated | Leerink Partners | Outperform |
View All
Zai Lab Limited Adr Stock (ZLAB) Latest News
Equitable Holdings Inc [EQH] Insider Lane Nick sells 5,000 Shares – Company Insider Activity - knoxdaily.com
Palantir Technologies Inc [PLTR] Insider Stat Lauren Elaina Friedman sells 800 Shares for $800 - knoxdaily.com
Zai Lab Limited ADR [ZLAB] Insider Smiley Joshua L sells 3,354 Shares – Latest News - knoxdaily.com
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors - Business Wire
JPMorgan Chase & Co. Buys 23,510 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy - Yahoo Finance
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Should You Buy? - Defense World
Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize
Orion Portfolio Solutions LLC Takes Position in Zai Lab Limited (NASDAQ:ZLAB) - The AM Reporter
Zai Lab (NASDAQ:ZLAB) Stock Price Down 7.1% on Insider Selling - Defense World
Analysts Recommend Holding Your Position In Zai Lab Limited ADR (NASDAQ: ZLAB) - Stocksregister
Zai Lab’s Joshua Smiley sells $111,044 in American Depositary Shares By Investing.com - Investing.com South Africa
Zai Lab CFO Chen Yajing sells $30,591 in American Depositary Shares By Investing.com - Investing.com South Africa
Zai Lab CFO Chen Yajing sells $30,591 in American Depositary Shares - Investing.com
Zai Lab's Joshua Smiley sells $111,044 in American Depositary Shares - Investing.com
Raymond James Financial Inc. Purchases Shares of 39,420 Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month High – What’s Next? - Defense World
Altice USA Inc [ATUS] Shares Jump Approximately 12.30% Over the Year - Knox Daily
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - BioSpace
US Bancorp DE Has $154,000 Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab (NASDAQ:ZLAB) Hits New 52-Week High Following Analyst Upgrade - Defense World
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Insider Monkey
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Reaches New 12-Month High – Still a Buy? - Defense World
Brokers Set Expectations for Zai Lab FY2025 Earnings - Defense World
Insider Sell: Richard Gaynor Sells 2,500 Shares of Zai Lab Ltd (ZLAB) - GuruFocus.com
Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - MSN
Zai Lab Limited's (NASDAQ:ZLAB) 31% Share Price Surge Not Quite Adding Up - simplywall.st
Leerink Partnrs Forecasts Zai Lab FY2026 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Receives “Neutral” Rating from Bank of America - Defense World
B of A Securities Downgrades Zai Lab LimitedDepositary Receipt () (ZLAB) - MSN
Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Q4 2024 Earnings Call Transcript - Insider Monkey
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Yahoo Finance
Equities Analysts Set Expectations for Zai Lab Q1 Earnings - Armenian Reporter
Here's Why 'Trend' Investors Would Love Betting on Zai Lab Limited (ZLAB) - MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Zai Lab Limited (ZLAB) Surges 9.0%: Is This an Indication of Further Gains? - Nasdaq
Q1 Earnings Forecast for Zai Lab Issued By Leerink Partnrs - Defense World
Financial Snapshot: Analyzing Zai Lab Limited ADR (ZLAB)’s Key Ratio Metrics - The Dwinnex
Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB) - Armenian Reporter
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance
Investors in Zai Lab (NASDAQ:ZLAB) from three years ago are still down 51%, even after 5.7% gain this past week - simplywall.st
Zai Lab Limited (NASDAQ:ZLAB) Short Interest Up 27.4% in January - Defense World
Sidley Advised Zai Lab on its Offering of ADSs and Issuance of Underlying Shares - Legal Desire News Network
Analysts Set Expectations for Zai Lab FY2024 Earnings - Defense World
Zai Lab Limited Adr Stock (ZLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zai Lab Limited Adr Stock (ZLAB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Edmondson Frazor Titus III | Chief Legal Officer |
Apr 04 '25 |
Sale |
33.11 |
1,874 |
62,044 |
30,375 |
| Du Ying | Chairperson & CEO |
Apr 04 '25 |
Sale |
33.11 |
2,945 |
97,503 |
479,851 |
| Chen Yajing | Chief Financial Officer |
Apr 04 '25 |
Sale |
33.11 |
924 |
30,592 |
27,047 |
| Amado Rafael | See Remarks |
Apr 04 '25 |
Sale |
33.11 |
3,029 |
100,284 |
45,178 |
1.75%
2.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):